Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Research Report 2024

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Cell Therapy
        1.2.3 Cell-derived Products
    1.3 Market by Application
        1.3.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Large Pharmaceutical Company
        1.3.3 Small and Medium-sized Pharmaceutical Company
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Perspective (2019-2030)
    2.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Trends by Region
        2.2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Region (2019-2024)
        2.2.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Region (2025-2030)
    2.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Dynamics
        2.3.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Trends
        2.3.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
        2.3.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Challenges
        2.3.4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Revenue
        3.1.1 Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Revenue (2019-2024)
        3.1.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Players (2019-2024)
    3.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players Ranking by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue
    3.4 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Concentration Ratio
        3.4.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue in 2023
    3.5 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Head office and Area Served
    3.6 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Product and Application
    3.7 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Breakdown Data by Type
    4.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Type (2019-2024)
    4.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Type (2025-2030)

 5 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Breakdown Data by Application
    5.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Application (2019-2024)
    5.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    6.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
    6.4 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    7.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
    7.4 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    8.2 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024)
    8.4 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    9.2 Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
    9.4 Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    10.2 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
    10.4 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Lonza
        11.1.1 Lonza Company Details
        11.1.2 Lonza Business Overview
        11.1.3 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.1.4 Lonza Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.1.5 Lonza Recent Development
    11.2 uBriGene Biosciences International
        11.2.1 uBriGene Biosciences International Company Details
        11.2.2 uBriGene Biosciences International Business Overview
        11.2.3 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.2.4 uBriGene Biosciences International Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.2.5 uBriGene Biosciences International Recent Development
    11.3 Thermo Fisher
        11.3.1 Thermo Fisher Company Details
        11.3.2 Thermo Fisher Business Overview
        11.3.3 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.3.4 Thermo Fisher Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.3.5 Thermo Fisher Recent Development
    11.4 Creative Biolabs
        11.4.1 Creative Biolabs Company Details
        11.4.2 Creative Biolabs Business Overview
        11.4.3 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.4.4 Creative Biolabs Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.4.5 Creative Biolabs Recent Development
    11.5 REPROCELL
        11.5.1 REPROCELL Company Details
        11.5.2 REPROCELL Business Overview
        11.5.3 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.5.4 REPROCELL Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.5.5 REPROCELL Recent Development
    11.6 ATCC
        11.6.1 ATCC Company Details
        11.6.2 ATCC Business Overview
        11.6.3 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.6.4 ATCC Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.6.5 ATCC Recent Development
    11.7 Beijing CytoNiche Biotech
        11.7.1 Beijing CytoNiche Biotech Company Details
        11.7.2 Beijing CytoNiche Biotech Business Overview
        11.7.3 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.7.4 Beijing CytoNiche Biotech Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.7.5 Beijing CytoNiche Biotech Recent Development
    11.8 OmniaBio
        11.8.1 OmniaBio Company Details
        11.8.2 OmniaBio Business Overview
        11.8.3 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.8.4 OmniaBio Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.8.5 OmniaBio Recent Development
    11.9 Histocell
        11.9.1 Histocell Company Details
        11.9.2 Histocell Business Overview
        11.9.3 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.9.4 Histocell Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.9.5 Histocell Recent Development
    11.10 FUJIFILM Diosynth Biotechnologies
        11.10.1 FUJIFILM Diosynth Biotechnologies Company Details
        11.10.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.10.3 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.10.4 FUJIFILM Diosynth Biotechnologies Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.10.5 FUJIFILM Diosynth Biotechnologies Recent Development
    11.11 Taiwan Bio Therapeutics
        11.11.1 Taiwan Bio Therapeutics Company Details
        11.11.2 Taiwan Bio Therapeutics Business Overview
        11.11.3 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.11.4 Taiwan Bio Therapeutics Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.11.5 Taiwan Bio Therapeutics Recent Development
    11.12 Encell Co., Ltd.
        11.12.1 Encell Co., Ltd. Company Details
        11.12.2 Encell Co., Ltd. Business Overview
        11.12.3 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.12.4 Encell Co., Ltd. Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.12.5 Encell Co., Ltd. Recent Development
    11.13 Mycenax
        11.13.1 Mycenax Company Details
        11.13.2 Mycenax Business Overview
        11.13.3 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.13.4 Mycenax Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.13.5 Mycenax Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Cell Therapy
 Table 3. Key Players of Cell-derived Products
 Table 4. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2019-2024)
 Table 8. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2025-2030)
 Table 10. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Trends
 Table 11. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
 Table 12. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Challenges
 Table 13. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints
 Table 14. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Players (2019-2024)
 Table 16. Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service as of 2023)
 Table 17. Ranking of Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Headquarters and Area Served
 Table 20. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Product and Application
 Table 21. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Type (2019-2024)
 Table 25. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Type (2025-2030)
 Table 27. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Application (2019-2024)
 Table 29. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Application (2025-2030)
 Table 31. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Lonza Company Details
 Table 47. Lonza Business Overview
 Table 48. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 49. Lonza Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 50. Lonza Recent Development
 Table 51. uBriGene Biosciences International Company Details
 Table 52. uBriGene Biosciences International Business Overview
 Table 53. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 54. uBriGene Biosciences International Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 55. uBriGene Biosciences International Recent Development
 Table 56. Thermo Fisher Company Details
 Table 57. Thermo Fisher Business Overview
 Table 58. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 59. Thermo Fisher Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 60. Thermo Fisher Recent Development
 Table 61. Creative Biolabs Company Details
 Table 62. Creative Biolabs Business Overview
 Table 63. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 64. Creative Biolabs Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 65. Creative Biolabs Recent Development
 Table 66. REPROCELL Company Details
 Table 67. REPROCELL Business Overview
 Table 68. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 69. REPROCELL Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 70. REPROCELL Recent Development
 Table 71. ATCC Company Details
 Table 72. ATCC Business Overview
 Table 73. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 74. ATCC Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 75. ATCC Recent Development
 Table 76. Beijing CytoNiche Biotech Company Details
 Table 77. Beijing CytoNiche Biotech Business Overview
 Table 78. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 79. Beijing CytoNiche Biotech Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 80. Beijing CytoNiche Biotech Recent Development
 Table 81. OmniaBio Company Details
 Table 82. OmniaBio Business Overview
 Table 83. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 84. OmniaBio Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 85. OmniaBio Recent Development
 Table 86. Histocell Company Details
 Table 87. Histocell Business Overview
 Table 88. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 89. Histocell Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 90. Histocell Recent Development
 Table 91. FUJIFILM Diosynth Biotechnologies Company Details
 Table 92. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 93. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 94. FUJIFILM Diosynth Biotechnologies Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 95. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 96. Taiwan Bio Therapeutics Company Details
 Table 97. Taiwan Bio Therapeutics Business Overview
 Table 98. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 99. Taiwan Bio Therapeutics Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 100. Taiwan Bio Therapeutics Recent Development
 Table 101. Encell Co., Ltd. Company Details
 Table 102. Encell Co., Ltd. Business Overview
 Table 103. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 104. Encell Co., Ltd. Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 105. Encell Co., Ltd. Recent Development
 Table 106. Mycenax Company Details
 Table 107. Mycenax Business Overview
 Table 108. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 109. Mycenax Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 110. Mycenax Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Picture
 Figure 2. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type: 2023 VS 2030
 Figure 4. Cell Therapy Features
 Figure 5. Cell-derived Products Features
 Figure 6. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application: 2023 VS 2030
 Figure 8. Large Pharmaceutical Company Case Studies
 Figure 9. Small and Medium-sized Pharmaceutical Company Case Studies
 Figure 10. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Report Years Considered
 Figure 11. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region: 2023 VS 2030
 Figure 14. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Players in 2023
 Figure 15. Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue in 2023
 Figure 17. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 19. United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. Canada Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 23. Germany Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. France Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. U.K. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Italy Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Russia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Nordic Countries Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2019-2030)
 Figure 31. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Southeast Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Australia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 39. Mexico Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Brazil Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 43. Turkey Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Saudi Arabia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. UAE Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Lonza Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 47. uBriGene Biosciences International Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 48. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 49. Creative Biolabs Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 50. REPROCELL Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 51. ATCC Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 52. Beijing CytoNiche Biotech Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 53. OmniaBio Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 54. Histocell Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 55. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 56. Taiwan Bio Therapeutics Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 57. Encell Co., Ltd. Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 58. Mycenax Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed